Matches in SemOpenAlex for { <https://semopenalex.org/work/W4283779061> ?p ?o ?g. }
Showing items 1 to 57 of
57
with 100 items per page.
- W4283779061 endingPage "4508" @default.
- W4283779061 startingPage "4497" @default.
- W4283779061 abstract "Methylprednisolone is commonly used to attenuate the cytokine storm and prevent mortality in COVID-19 pneumonia. However, the optimal methylprednisolone dose and duration are unclear. Additional data are required on the effectiveness of methylprednisolone in reducing mortality in COVID-19. This real-life retrospective study aimed to analyze the data of a COVID-19 dedicated ICU and compare the mortality rates of standard care, low-dose, and pulse-dose methylprednisolone in patients requiring mechanical ventilatory support.Methylprednisolone's indication, dose, and duration were determined according to the severity of COVID-19 pneumonia based on the patient's demographic parameters, comorbidities, laboratory data, radiology, and arterial blood gas analysis results. 867 patients were grouped as: no methylprednisolone (standard care), low-dose (0.5-1 mg/kg/day) methylprednisolone or pulse-dose (250-1,000 mg/day) methylprednisolone.The overall mortality rate was 63.78%. Adjusting the dose of methylprednisolone according to the severity of the disease resulted in statistically similar mortality rates despite the increase in disease severity. Mortality was 62.71% in standard treatment, 65.76% in low-dose, and 62.10% in pulse-dose methylprednisolone groups (p = 0.633). Invasive mechanical ventilation at admission was associated with increased mortality (HR: 1.826 [95% CI: 1.542-2.161]; p < 0.001). Hematologic disorders and malignancies, arterial blood pH and HCO3, neutrophil count, and NLR at admission were also associated with mortality.Personalizing the dose and duration of methylprednisolone according to the patient's disease severity assessed with demographic, clinical, and laboratory results may benefit mortality in severe COVID-19 patients receiving ventilatory support in the ICU. Hematologic disorders and malignancies, arterial blood pH and HCO3, neutrophil count, and NLR at admission were associated with mortality in our patient cohort." @default.
- W4283779061 created "2022-07-03" @default.
- W4283779061 creator A5002492084 @default.
- W4283779061 creator A5007878960 @default.
- W4283779061 creator A5014851712 @default.
- W4283779061 creator A5073975482 @default.
- W4283779061 creator A5084847503 @default.
- W4283779061 creator A5085512753 @default.
- W4283779061 date "2022-06-01" @default.
- W4283779061 modified "2023-09-27" @default.
- W4283779061 title "Evaluation of personalized methylprednisolone therapy in critically ill COVID-19 patients: an observational comparative study using real-life data." @default.
- W4283779061 doi "https://doi.org/10.26355/eurrev_202206_29089" @default.
- W4283779061 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35776051" @default.
- W4283779061 hasPublicationYear "2022" @default.
- W4283779061 type Work @default.
- W4283779061 citedByCount "0" @default.
- W4283779061 crossrefType "journal-article" @default.
- W4283779061 hasAuthorship W4283779061A5002492084 @default.
- W4283779061 hasAuthorship W4283779061A5007878960 @default.
- W4283779061 hasAuthorship W4283779061A5014851712 @default.
- W4283779061 hasAuthorship W4283779061A5073975482 @default.
- W4283779061 hasAuthorship W4283779061A5084847503 @default.
- W4283779061 hasAuthorship W4283779061A5085512753 @default.
- W4283779061 hasConcept C126322002 @default.
- W4283779061 hasConcept C179755657 @default.
- W4283779061 hasConcept C2777080012 @default.
- W4283779061 hasConcept C2777914695 @default.
- W4283779061 hasConcept C2780372218 @default.
- W4283779061 hasConcept C42219234 @default.
- W4283779061 hasConcept C71924100 @default.
- W4283779061 hasConceptScore W4283779061C126322002 @default.
- W4283779061 hasConceptScore W4283779061C179755657 @default.
- W4283779061 hasConceptScore W4283779061C2777080012 @default.
- W4283779061 hasConceptScore W4283779061C2777914695 @default.
- W4283779061 hasConceptScore W4283779061C2780372218 @default.
- W4283779061 hasConceptScore W4283779061C42219234 @default.
- W4283779061 hasConceptScore W4283779061C71924100 @default.
- W4283779061 hasIssue "12" @default.
- W4283779061 hasLocation W42837790611 @default.
- W4283779061 hasOpenAccess W4283779061 @default.
- W4283779061 hasPrimaryLocation W42837790611 @default.
- W4283779061 hasRelatedWork W10321994 @default.
- W4283779061 hasRelatedWork W11630410 @default.
- W4283779061 hasRelatedWork W1432241 @default.
- W4283779061 hasRelatedWork W14821565 @default.
- W4283779061 hasRelatedWork W18589207 @default.
- W4283779061 hasRelatedWork W5783616 @default.
- W4283779061 hasRelatedWork W6524990 @default.
- W4283779061 hasRelatedWork W9461323 @default.
- W4283779061 hasRelatedWork W4339174 @default.
- W4283779061 hasRelatedWork W5425706 @default.
- W4283779061 hasVolume "26" @default.
- W4283779061 isParatext "false" @default.
- W4283779061 isRetracted "false" @default.
- W4283779061 workType "article" @default.